Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)

SHA:603896 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	731.5	853.64	1,504	1,525	677.98	669.25
Trading Asset Securities	366.67	344.69	-	30	130	50
Cash & Short-Term Investments	1,098	1,198	1,504	1,555	807.98	719.25
Cash Growth	-32.29%	-20.32%	-3.26%	92.42%	12.34%	77.98%
Accounts Receivable	123.42	119.31	113.06	137.68	117.25	81.79
Other Receivables	3.7	2.86	3.25	2.51	3.36	2.53
Receivables	127.12	122.16	116.32	140.19	120.61	84.33
Inventory	197.37	179.55	157.83	147.76	99.06	99.38
Other Current Assets	22.37	22.3	28.73	19.35	17.64	19.85
Total Current Assets	1,445	1,522	1,807	1,862	1,045	922.8
Property, Plant & Equipment	979.54	914.24	682.32	601.14	515.91	373.66
Long-Term Investments	95.83	94.85	65.71	63.8	66.46	82.12
Other Intangible Assets	349.57	352.86	310.98	78.16	82.98	78.58
Long-Term Deferred Tax Assets	-	-	-	-	0.37	1.04
Long-Term Deferred Charges	62.35	68.65	79.78	53.13	39.93	27.73
Other Long-Term Assets	183.41	178.24	228.71	197.94	211.51	213.65
Total Assets	3,116	3,131	3,174	2,856	1,962	1,700
Accounts Payable	159.16	132.1	132.71	103.98	107.94	56.61
Accrued Expenses	17.91	36.88	40.28	71.15	54.03	54.25
Short-Term Debt	94.79	187.4	372.16	272.97	-	-
Current Portion of Leases	12.49	15.4	12.08	4.87	5.63	-
Current Income Taxes Payable	1.67	-	0.02	0.24	0.02	1.42
Current Unearned Revenue	12.88	11.64	10.1	9.03	9.61	7.72
Other Current Liabilities	5.56	6.75	17.79	15.53	22.05	44.7
Total Current Liabilities	304.46	390.18	585.15	477.77	199.28	164.69
Long-Term Debt	367.24	361.01	340.19	412.59	87.6	188.13
Long-Term Leases	27.38	22.76	23.97	15.97	13.33	-
Long-Term Unearned Revenue	54.91	54.86	49.98	41.3	38.23	16.12
Long-Term Deferred Tax Liabilities	8.51	8.35	3.78	3.04	3.98	4.34
Total Liabilities	762.49	837.17	1,003	950.67	342.41	373.28
Common Stock	198.24	198.24	201.83	197.2	152.5	148.01
Additional Paid-In Capital	804.52	804.52	966.03	856.25	900.22	768.82
Retained Earnings	1,231	1,173	1,076	908.45	690.99	536.05
Treasury Stock	-	-	-165.11	-165.11	-165.11	-194.12
Comprehensive Income & Other	119	118.15	92.83	108.73	41.06	67.56
Total Common Equity	2,353	2,294	2,171	1,906	1,620	1,326
Minority Interest	-	-	-	-	0.38	-
Shareholders' Equity	2,353	2,294	2,171	1,906	1,620	1,326
Total Liabilities & Equity	3,116	3,131	3,174	2,856	1,962	1,700
Total Debt	501.89	586.57	748.4	706.41	106.56	188.13
Net Cash (Debt)	596.27	611.76	755.56	848.31	701.42	531.12
Net Cash Growth	-29.83%	-19.03%	-10.93%	20.94%	32.06%	34.76%
Net Cash Per Share	2.99	3.08	3.86	4.37	3.67	2.88
Filing Date Shares Outstanding	198.24	198.24	198.24	197.2	198.25	192.41
Total Common Shares Outstanding	198.24	198.24	198.24	197.2	198.25	192.41
Working Capital	1,141	1,132	1,222	1,384	846.02	758.11
Book Value Per Share	11.87	11.57	10.95	9.66	8.17	6.89
Tangible Book Value	2,004	1,941	1,860	1,827	1,537	1,248
Tangible Book Value Per Share	10.11	9.79	9.38	9.27	7.75	6.48
Buildings	-	350.9	308.29	357.46	355.62	194.11
Machinery	-	250.68	241.18	198.58	145.46	121.26
Construction In Progress	-	501.72	280.21	169.63	115.34	155.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.